Scroll to top

2019 Announcements

CLINUVEL
Posted by CLINUVEL
December 23, 2019

SCENESSE® registration dossier submitted in Australia

CLINUVEL initiates the registration process under priority review for its new pharmaceutical...

Read More
CLINUVEL
Posted by CLINUVEL
December 10, 2019

Notice of Change of Interests of Substantial Holder

  Form 604 – Notice of change of interests of substantial holder...

Read More
CLINUVEL
Posted by CLINUVEL
December 9, 2019

Change of Director's Interest Notice

Appendix 3Y – Change of Director’s Interest Notice, is available to download.

Read More
CLINUVEL
Posted by CLINUVEL
December 6, 2019

Lapse and Forfeit of Unlisted Conditional Performance Rights

CLINUVEL PHARMACEUTICALS LTD wishes to advise in accordance with the terms and...

Read More
CLINUVEL
Posted by CLINUVEL
December 5, 2019

Changes of Director's Interest Notice

Appendix 3Y Change of Director’s Interest Notice Download PDF

Read More
CLINUVEL
Posted by CLINUVEL
December 5, 2019

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement. Download...

Read More
CLINUVEL
Posted by CLINUVEL
December 5, 2019

Changes in Composition to Committeess

CLINUVEL PHARMACEUTICALS LTD today announced changes to the composition of its Audit...

Read More
CLINUVEL
Posted by CLINUVEL
December 2, 2019

CEO Letter

  Dear shareholders,   On 8 October 2019, CLINUVEL obtained its first...

Read More
CLINUVEL
Posted by CLINUVEL
November 26, 2019

Appendix 3X

Initial Director’s Interest Notice. Download PDF

Read More
CLINUVEL
Posted by CLINUVEL
November 26, 2019

CLINUVEL Appoints Non-Executive Director

CLINUVEL PHARMACEUTICALS LTD today announced the appointment of Professor Jeffrey Rosenfeld as...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2019

Chair’s Address to the Annual General Meeting

Melbourne, Australia, 20 November 2019 A MOMENTOUS ACHIEVEMENT Looking at the year...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2019

Results of Meeting

  Results of Annual General Meeting In accordance with Listing Rule 3.13.2...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2019

Managing Director's AGM Presentation

Melbourne, Australia, 20 November 2019 “We are here today to reflect on...

Read More
CLINUVEL
Posted by CLINUVEL
October 31, 2019

Appendix 4C

CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company focused on developing and delivering...

Read More
CLINUVEL
Posted by CLINUVEL
October 30, 2019

TGA Priority Registration Pathway for SCENESSE

CLINUVEL PHARMACEUTICALS LTD today announced that the Australian Therapeutic Goods Administration (TGA)...

Read More
CLINUVEL
Posted by CLINUVEL
October 30, 2019

Letter from the Remuneration Committee Chair

Dearest Shareholders, As the incoming Chair of the Company, in short letters...

Read More
We use cookies to give you the best experience.